Home

JAZZ

JAZZ

The Future of Biotech: Party Like It's 1999

Submitted by Free Investing on Sun, 01/17/2010 - 10:57

Joseph Krueger submits: At the 28th annual JP Morgan Healthcare conference, which ran from January 11- January 14th 2010, there were more than 300 companies represented, making their presentations to more than 6000 public and private equity and venture capital investors.Leading up to the conference and early last week there was bullish movement in many companies presenting at the conference. Many of the many of the larger companies like Amgen (AMGN), Genzyme (GENZ), Biogen (BIIB), Celgene (CELG), Gilead Sciences (GILD), TEVA Pharmaceuticals TEVA), Watson Pharmaceuticals (WPI) and OSI Pharmaceuticals (OSIP) previewed 2009 earnings during the conference.Complete Story »

Tuesday Options Recap

Submitted by Free Investing on Tue, 11/24/2009 - 16:58

Frederic Ruffy submits: SentimentThe major averages battled back from early weakness and are trading mixed late Tuesday. The table was set for morning losses after data showed the US economy growing at a 2.8 percent annual rate in the third quarter, which was revised down from an initial reading of 3.4 percent. The number was in-line with economist estimates, but the data also showed consumer spending increasing 2.9 percent and less than the 3.4 percent initially reported. A wider trade deficit and less business investment were also responsible for the lower GDP number.Complete Story »

Syndicate content